Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Flotation/IPO

Zhonggu Logistics to move onto stock exchange
Zhonggu Logistics has filed for a $218m on the Shanghai Stock Exchange, providing exits to Zhonggu Shipping and SoftBank.
Compass navigates IPO
Compass Pathways has raised more than $127m in an upsized initial public offering that provided an exit to Otsuka Pharmaceuticals.
Analysis: Snowflake goes public
Data management software provider Snowflake, which counts Salesforce among its backers, went public last week and its price doubled on the first day of trading.
Amwell rams its way to $742m IPO
The telehealth system provider is going public in an $742m upsized offering that will enable Philips, Allianz, Teva and Takeda to exit.
Outset Medical pumps IPO up to $278m
The kidney dialysis technology provider has added about $36m to close its initial public offering, it shares having more than doubled in price.
Kuaishou to cook up $5bn IPO
Tencent is the largest shareholder of short-form video app developer Kuaishou, which is reportedly looking to boost its valuation to $50bn in a January offering.
JFrog jumps IPO up to $509m
Dell's stake in the software release technology provider is sized at almost $490m following an initial public offering in which it floated well above its range.
Metacrine shows mettle in $85m IPO
Lilly Asia Ventures achieved an exit as the gastrointestinal and liver disease drug developer priced its initial public offering in the middle of its range.

Other News

Snowflake hits public markets in $3.36bn IPO
Salesforce Ventures will invest another $250m as the data management software provider floated above its range at a valuation just short of $29bn.
Outset Medical outpaces expectations in $242m IPO
Baxter International scored an exit as dialysis machine developer Outset Medical floated above its range in an upsized offering.
Oncorus goes on to IPO stage
Astellas and Celgene-backed immuno-oncology therapy developer Oncorus has filed to raise up to $86.3m following more than $150m in funding.
C4 Therapeutics sees its way to IPO filing
Kraft Group, Roche and Novartis are in line for exits after small molecule drug developer C4 filed for a $100m offering,
Codiak comes back for second IPO attempt
Alexandria Real Estate Equities-backed exosome therapy developer Codiak Biosciences has filed to raise up to $100m having pulled back from an earlier offering last year.
3Peak seeks $339m in IPO
Huawei’s venture capital arm Hubble Technologies is in line for an exit less than nine months after it invested in fabless semiconductor maker 3Peak.

Editor's Picks

Amwell rams its way to $742m IPO
The telehealth system provider is going public in an $742m upsized offering that will enable Philips, Allianz, Teva and Takeda to exit.
Snowflake hits public markets in $3.36bn IPO
Salesforce Ventures will invest another $250m as the data management software provider floated above its range at a valuation just short of $29bn.
Grail to pour itself on to public markets
Illumina's cancer diagnostics spinoff, which has raised more than $1.9bn in funding, has filed to float on the Nasdaq Global Select Market.
Xpeng extracts $1.5bn from initial public offering
The Alibaba, Xiaomi, Foxconn, UCar and Duowan-backed smart electric carmaker has floated in the US through an offering valuing it in excess of $21bn.
test reg

Login